NICE recommends Sucampo’s Amitiza for chronic idiopathic constipation treatment

The UK National Institute of Health and Care Excellence (NICE) has recommended Sucampo Pharmaceuticals' Amitiza (lubiprostone) as a treatment option for chronic idiopathic constipation (CIC) and associated symptoms in adults who have failed laxatives…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news